Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,602 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased Non-Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan-Based Regimen.
Shinohara A, Shindo M, Nakano N, Sakaida E, Uchida N, Fukushima K, Nakazawa H, Serizawa K, Kanda Y, Kawakita T, Ikeda T, Ohigashi H, Ito A, Wakayama T, Matsuoka KI, Fukuda T, Tanaka J, Atsuta Y, Nakasone H. Shinohara A, et al. Among authors: fukushima k. Eur J Haematol. 2025 Jan 20. doi: 10.1111/ejh.14374. Online ahead of print. Eur J Haematol. 2025. PMID: 39834012
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT.
Kawamura S, Nakagawa D, Nagayama T, Katayama Y, Doki N, Takeda W, Nishida T, Matsuoka KI, Ikeda T, Ohigashi H, Sawa M, Fukushima K, Kanda J, Serizawa K, Onizuka M, Fukuda T, Atsuta Y, Kanda Y, Nakasone H. Kawamura S, et al. Among authors: fukushima k. Blood Adv. 2025 Jan 14:bloodadvances.2024014408. doi: 10.1182/bloodadvances.2024014408. Online ahead of print. Blood Adv. 2025. PMID: 39808797
The Gut-Kidney Axis in Chronic Kidney Diseases.
Tsuji K, Uchida N, Nakanoh H, Fukushima K, Haraguchi S, Kitamura S, Wada J. Tsuji K, et al. Among authors: fukushima k. Diagnostics (Basel). 2024 Dec 25;15(1):21. doi: 10.3390/diagnostics15010021. Diagnostics (Basel). 2024. PMID: 39795549 Free PMC article. Review.
Successful treatment with bortezomib for refractory cryoglobulinemic vasculitis triggered by ischemic non-obstructive coronary artery disease.
Ohta Y, Tsuchiya T, Oka M, Tachibana M, Kondo Y, Fukushima K, Matsuno S, Yamanaka N, Suzuki N, Komatsu A, Rokutan H, Yumura W, Arai T, Ishigami A, Itabashi M, Takei T. Ohta Y, et al. Among authors: fukushima k. CEN Case Rep. 2025 Jan 6. doi: 10.1007/s13730-024-00963-2. Online ahead of print. CEN Case Rep. 2025. PMID: 39760978 Free article.
Treatment Outcomes of Tyrosine Kinase Inhibitors and Durvalumab Plus Tremelimumab After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma.
Ishihara N, Komatsu S, Yano Y, Fujishima Y, Ishida J, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Tai K, Arai K, Yanagimoto H, Toyama H, Matsuura T, Tada T, Kodama Y, Fukumoto T. Ishihara N, et al. Among authors: fukushima k. Anticancer Res. 2025 Jan;45(1):251-260. doi: 10.21873/anticanres.17412. Anticancer Res. 2025. PMID: 39740814
2,602 results